An overview of matrix metalloproteinases in the pathogenesis and treatment of abdominal aortic aneurysms

Vascular and Endovascular Surgery

Volumn 39, Issue 6, 2005, Pages 457-464

  Keeling, W Brent ^a,b   Armstrong, Paul A ^a,b   Stone, Patrick A ^a,b   Bandyk, Dennis F ^a,b   Shames, Murray L ^a,b  

^a University of South Florida College of Medicine ^*  (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; COLLAGEN TYPE 1; COLLAGEN TYPE 4; DOXYCYCLINE; ELASTASE; FIBRINOGEN; GELATINASE A; GELATINASE B; MACROPHAGE ELASTASE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; RETROVIRUS VECTOR; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ABDOMINAL AORTA ANEURYSM; ATHEROMA; COLLAGEN DEGRADATION; ELASTOLYSIS; ENDOVASCULAR SURGERY; ENZYME SUBSTRATE; EXPERIMENTAL RAT; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; KNOCKOUT MOUSE; NONHUMAN; PATHOGENESIS; REVIEW; SYSTEMATIC REVIEW; VASCULAR SMOOTH MUSCLE; WILD TYPE;

ANIMALS; AORTIC ANEURYSM, ABDOMINAL; BIOLOGICAL MARKERS; BIOPSY, NEEDLE; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TISSUE INHIBITOR OF METALLOPROTEINASE-3; TISSUE INHIBITOR OF METALLOPROTEINASES; TREATMENT OUTCOME;

EID: 29044441064     PISSN: 15385744     EISSN: None     Source Type: Journal    
DOI: 10.1177/153857440503900601     Document Type: Review

References (38)

1. Yao JS: Commentary: Surgical treatment of aortic aneurysm: 50-some years later. Cardiovasc Surg 11:413-415, 2003.
2. Melton LJ III, Bickerstaff LK, Hollier LH, et al: Changing incidence of abdominal aortic aneurysms: A population-based study. Am J Epidemiol 120:379-386, 1984.
3. Bickerstaff LK, Hollier LH, Van Peenen HJ, et al: Abdominal aortic aneurysms: The changing natural history. J Vasc Surg 1:6-12, 1984.
4. Saus J, Quinones S, Otani Y, et al: The complete primary structure of human matrix metalloproteinase-3. Identity with stromelysin. J Biol Chem 263:6742-6745, 1988.
5. Ogata Y, Enghild JJ, Nagase H: Matrix metalloproteinase-3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. J Biol Chem 267:3581-3584, 1992.
6. Wilhelm SM, Collier IE, Marmer BL, et al: SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem 264:17213-17221, 1989.
7. Moll UM, Lane B, Zucker S, et al: Localization of collagenase at the basal plasma membrane of a human pancreatic carcinoma cell line. Cancer Res 50:6995-7002, 1990.
8. Senior RM, Griffin GL, Fliszar CJ, et al: Human 92- and and 72-kilodalton type IV collagenases are elastases. J Biol Chem 266:7870-7875, 1991.
9. Irizarry E, Newman KM, Gandhi RH, et al: Demonstration of interstitial collagenase in abdominal aortic aneurysm disease. J Surg Res 54:571-574, 1993.
10. Newman KM, Jean-Claude J, Li H, et al: Cellular localization of matrix metalloproteinases in the abdominal aortic aneurysm wall. J Vasc Surg 20:814-820, 1994.
11. Sires UI, Griffin GL, Broekelmann TJ, et al: Degradation of entactin by matrix metalloproteinases. Susceptibility to matrilysin and identification of cleavage sites. J Biol Chem 268:2069-2074, 1993.
12. Birkedal-Hansen H, Moore WG, Bodden MK, et al: Matrix metalloproteinases: A review. Crit Rev Oral Biol Med 4:197-250, 1993.
13. Tung WS, Lee JK, Thompson RW: Simultaneous analysis of 1,176 gene products in normal human aorta and abdominal aortic aneurysms using a membrane-based complementary DNA expression array. J Vasc Surg 34:143-150, 2001.
14. Patel MI, Melrose J, Ghosh P, et al: Increased synthesis of matrix metalloproteinases by aortic smooth muscle cells is implicated in the etiopathogenesis of abdominal aortic aneurysms. J Vasc Surg 24:82-92, 1996.
15. McMillan WD, Tamarina NA, Cipollone M, et al: Size matters: The relationship between MMP-9 expression and aortic diameter. Circulation 96:2228-2232, 1997.
16. Petersen E, Wagberg F, Angquist KA: Proteolysis of the abdominal aortic aneurysm wall and the association with rupture. Eur J Vasc Endovasc Surg 23:153-157, 2002.
17. Millan WD, Pearce WH: Increased plasma levels of metalloproteinase-9 are associated with abdominal aortic aneurysms. J Vasc Surg 29:122-127; discussion 127-129, 1999.
18. Lorelli DR, Jean-Claude JM, Fox CJ, et al: Response of plasma matrix metalloproteinase-9 to conventional abdominal aortic aneurysm repair or endovascular exclusion: Implications for endoleak. J Vasc Surg 35:916-922, 2002.
19. Sangiorgi G, D'Averio R, Mauriello A, et al: Plasma levels of metalloproteinases-3 and -9 as markers of successful abdominal aortic aneurysm exclusion after endovascular graft treatment. Circulation 104(12 Suppl 1):I288-I295, 2001.
20. Petrinec D, Liao S, Holmes DR, et al: Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: Preservation of aortic elastin associated with suppressed production of 92 kD gelatinase. J Vasc Surg 23:336-346, 1996.
21. Holmes DR, Petrinec D, Wester W, et al: Indomethacin prevents elastase-induced abdominal aortic aneurysms in the rat. J Surg Res 63:305-309, 1996.
22. Pyo R, Lee JK, Shipley JM, et al: Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest 105:1641-1649, 2000.
23. Baxter BT, Pearce WH, Waltke EA, et al: Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: Report of a prospective (Phase II) multicenter study. J Vasc Surg 36:1-12, 2002.
24. Mosorin M, Juvonen J, Biancari F, et al: Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: A randomized, double-blind, placebo-controlled pilot study. J Vasc Surg 34:606-610, 2001.
25. Freestone T, Turner RJ, Coady A, et al: Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 15:1145-1151, 1995.
26. Davis V, Persidskaia R, Baca-Regen L, et al: Matrix metalloproteinase-2 production and its binding to the matrix are increased in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 18:1625-1633, 1998.
27. Goodall S, Crowther M, Hemingway DM, et al: Ubiquitous elevation of matrix metalloproteinase-2 expression in the vasculature of patients with abdominal aneurysms. Circulation 104:304-309, 2001.
28. Goodall S, Porter KE, Bell PR, et al: Enhanced invasive properties exhibited by smooth muscle cells are associated with elevated production of MMP-2 in patients with aortic aneurysms. Eur J Vasc Endovasc Surg 24:72-80, 2002.
29. Treharne GD, Boyle JR, Goodall S, et al: Marimastat inhibits elastin degradation and matrix metalloproteinase 2 activity in a model of aneurysm disease. Br J Surg 86:1053-1058, 1999.
30. Liu J, Xiong W, Baca-Regen L, et al: Mechanism of inhibition of matrix metalloproteinase-2 expression by doxycycline in human aortic smooth muscle cells. J Vasc Surg 38:1376-1383, 2003.
31. Nagashima H, Aoka Y, Sakomura Y, et al: Matrix metalloproteinase-2 is suppressed by trapidil, a CD40-CD40 ligand pathway inhibitor, in human abdominal aortic aneurysm wall. J Vasc Surg 39:447-453, 2004.
32. Carrell TW, Burnand KG, Wells GM, et al: Stromelysin-1 (matrix metalloproteinase-3) and tissue inhibitor of metalloproteinase-3 are overexpressed in the wall of abdominal aortic aneurysms. Circulation 105:477-482, 2002.
33. Curci JA, Liao S, Huffman MD, et al: Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms. J Clin Invest 102:1900-1910, 1998.
34. Stetler-Stevenson WG, Krutzsch HC, Liotta LA: Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family. J Biol Chem 264:17374-17378, 1989.
35. Knox JB, Sukhova GK, Whittemore AD, et al: Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases. Circulation 95:205-212, 1997.
36. Allaire E, Forough R, Clowes M, et al: Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model. J Clin Invest 102:1413-1420, 1998.
37. Nishimura K, Ikebuchi M, Kanaoka Y, et al: Relationships between matrix metalloproteinases and tissue inhibitor of metalloproteinases in the wall of abdominal aortic aneurysms. Int Angiol 22:229-238, 2003.
38. Eskandari MK, Vijungco JD, Flores A, et al: Enhanced abdominal aortic aneurysm in TIMP-1-deficient mice. J Surg Res 123:289-293, 2005.